Oncotarget

Reviews:

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms

Xuefei Huang, Jing Yang, Sijin Yang, Shousong Cao, Dalian Qin, Ya Zhou, Xiaoli Li, Yun Ye and Jianming Wu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:102705-102720. https://doi.org/10.18632/oncotarget.22170

Metrics: PDF 951 views  |   HTML 3196 views  |   ?  


Abstract

Xuefei Huang1,*, Jing Yang2,*, Sijin Yang3,*, Shousong Cao4, Dalian Qin2, Ya Zhou1, Xiaoli Li5, Yun Ye1,6 and Jianming Wu2

1Department of Clinical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China

2Laboratory of Chinese Materia Medica, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China

3Department of Cardiology and Neurology, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, China

4Laboratory of Cancer Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China

5Department of R&D, Sichuan CREDIT Pharmaceutical Ltd., Luzhou, Sichuan, 646000, China

6Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China

*These authors have contributed equally to this work

Correspondence to:

Jianming Wu, email: jianmingwu@swmu.edu.cn

Yun Ye, email: yeyun8622@163.com

Keywords: tandospirone; 5-HT1A receptor; Parkinson's disease; schizophrenia; mechanisms

Received: July 26, 2017     Accepted: September 20, 2017     Published: October 27, 2017

ABSTRACT

5-hydroxytryptamine (5-HT, serotonin) is an important neurotransmitter in the modulation of the cognitive, behavioral and psychological functions in animals and humans. Among the fourteen subtypes of 5-HT receptor, 5-HT1A receptor has been extensively studied. Tandospirone, an azapirone derivative with strong and selective agonist effect on 5-HT1A receptor, has been used for the treatment of anxiety disorders especially generalized anxiety disorder for decades. Recently, tandospirone showed the efficacy in relieving the syndromes of social anxiety disorder and post-traumatic stress disorder as well as in potentiating the effect of antidepressants in the treatment of depression in both preclinical and clinical studies. More impressively, the beneficial effect of tandospirone has been revealed on improvement of motor dysfunction of Parkinson’s disease and cognitive deficits of schizophrenia either in monotherapy or in combination with other drugs. This review discusses the superiority of tandospirone in the treatment of the disorders and associated mechanisms in central nervous system from the literature.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22170